You need to have the Flash Player installed and
a browser with JavaScript support.
Description
Combining a breast cancer patient's clinical characteristics with a genomic profile of her tumor may provide important information for predicting an individual patient's prognosis and accurately guiding treatment options, according to a new study led by researchers in the Duke Comprehensive Cancer Center (DCCC) and Duke's Institute for Genome Sciences & Policy (IGSP). The findings appear in the April 2, 2008 issue of the Journal of the American Medical Association.
Sign in or sign up to post comments.